DXCM
DexCom, Inc. · Healthcare · Medical Devices
TECHSellZACKSHold
R500#420 today
$85.36
-1.01% today · -1.45% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- DXCM −1.01% on the last session vs SPY +0.74%: −1.7 pts of stock-specific move.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 29
After the close · in 25 days
EPS estimate
$0.67
$0.62 to $0.72 · 21 analysts
Revenue estimate
$1.3B
$1.3B to $1.3B
Track record
6/8 beats
last 8 reports · moved ±8.8% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2026 AMC | 2Q2026 | $0.61 | $0.70 | +$0.09 (+15.1%) beat | $1.3B | +11.9% +11.2 vs SPY | +7.2% | +11.4% |
| Apr 30, 2026 AMC | 1Q2026 | $0.47 | $0.56 | +$0.09 (+19.0%) beat | $1.2B | +3.0% +2.7 vs SPY | +2.4% | +2.3% |
| Feb 12, 2026 AMC | 4Q2025 | $0.65 | $0.68 | +$0.03 (+4.5%) beat | $1.3B | +7.6% +7.5 vs SPY | -1.0% | +12.3% |
| Oct 30, 2025 AMC | 3Q2025 | $0.57 | $0.61 | +$0.04 (+7.5%) beat | $1.2B | -14.6% -15.0 vs SPY | -13.2% | -14.9% |
| Jul 30, 2025 AMC | $0.44 | $0.48 | +$0.04 (+9.1%) beat | — | -9.3% -8.9 vs SPY | -3.8% | -14.2% | |
| May 1, 2025 AMC | $0.33 | $0.32 | −$0.01 (−3.0%) miss | — | +16.2% +14.7 vs SPY | +7.1% | +21.5% | |
| Feb 13, 2025 AMC | $0.50 | $0.45 | −$0.05 (−10.0%) miss | — | +5.9% +5.9 vs SPY | +2.3% | +5.6% | |
| Oct 24, 2024 AMC | $0.43 | $0.45 | +$0.02 (+4.7%) beat | — | -1.9% -1.9 vs SPY | -1.9% | -5.8% | |
| Jul 25, 2024 AMC | $0.39 | $0.43 | +$0.04 (+10.3%) beat | — | -40.7% -41.8 vs SPY | -38.8% | -34.8% | |
| Apr 25, 2024 AMC | $0.27 | $0.32 | +$0.05 (+18.5%) beat | — | -9.9% -10.9 vs SPY | -4.0% | -8.2% | |
| Feb 8, 2024 AMC | $0.43 | $0.50 | +$0.07 (+16.3%) beat | — | -5.2% -5.8 vs SPY | -3.2% | -7.4% | |
| Oct 26, 2023 AMC | $0.33 | $0.50 | +$0.17 (+51.5%) beat | — | +10.1% +10.6 vs SPY | +14.3% | +15.5% | |
| Jul 27, 2023 AMC | $0.23 | $0.34 | +$0.11 (+47.8%) beat | — | +2.3% +1.4 vs SPY | +3.9% | -5.6% | |
| Apr 27, 2023 AMC | $0.15 | $0.17 | +$0.02 (+13.3%) beat | — | -1.8% -2.7 vs SPY | -3.5% | -5.0% | |
| Feb 9, 2023 AMC | $0.28 | $0.34 | +$0.06 (+21.4%) beat | — | +9.9% +9.7 vs SPY | +5.0% | +9.3% | |
| Oct 27, 2022 AMC | $0.24 | $0.28 | +$0.04 (+16.7%) beat | — | +19.4% +17.0 vs SPY | +12.3% | +11.2% | |
| Jul 28, 2022 AMC | $0.19 | $0.17 | −$0.02 (−10.5%) miss | — | -5.6% -7.1 vs SPY | -10.1% | +2.9% | |
| Apr 28, 2022 AMC | $0.13 | $0.08 | −$0.05 (−38.5%) miss | — | -1.1% +2.6 vs SPY | -0.2% | -8.2% | |
| Feb 10, 2022 AMC | $0.21 | $0.17 | −$0.04 (−19.0%) miss | — | -4.9% -2.9 vs SPY | -3.7% | -12.4% | |
| Oct 28, 2021 AMC | $0.16 | $0.22 | +$0.06 (+37.5%) beat | — | +9.3% +9.1 vs SPY | +1.7% | +10.4% | |
| Jul 29, 2021 AMC | $0.11 | $0.19 | +$0.08 (+72.7%) beat | — | — | — | — | |
| Apr 29, 2021 AMC | $0.07 | $0.08 | +$0.01 beat | — | — | — | — | |
| Feb 11, 2021 AMC | $0.23 | $0.23 | $0.00 (0.0%) in line | — | — | — | — | |
| Oct 27, 2020 AMC | $0.16 | $0.24 | +$0.08 (+50.0%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $0.67 (21) | $0.62 – $0.72 | +10% | -0.3% | ▲7 ▼9 | $1.3B | +10% |
| Next quarter · Dec 31, 2026 | $0.73 (21) | $0.70 – $0.77 | +8% | -2.1% | ▲5 ▼12 | $1.4B | +11% |
| Current year · Dec 31, 2026 | $2.66 (25) | $2.45 – $2.75 | +27% | +3.0% | ▲23 ▼0 | $5.2B | +12% |
| Next year · Dec 31, 2027 | $3.12 (25) | $2.83 – $3.29 | +17% | +1.6% | ▲18 ▼4 | $5.8B | +11% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.